Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IGIV-C 10% Rapid Infusion Trial in Primary Immune Deficient Patients

NCT00220766 is registered in ClinicalTrials.gov with Grifols Therapeutics LLC as lead sponsor.

NCT NCT00220766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00220766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IGIV-C 10% Rapid Infusion Trial in Primary Immune Deficient Patients
Lead sponsor
Grifols Therapeutics LLC
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2002
Completion date
March 31, 2004
Enrollment
100 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

agammaglobulinemia, common variable immunodeficiency, immunologic deficiency syndrome, severe combined immunodeficiency, wiskott-aldrich syndrome